Miltenyi Biotec
910 Clopper Rd #200
Gaithersburg
Maryland
20878
United States
24 articles about Miltenyi Biotec
-
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
12/18/2023
Replay today announced a licensing and manufacturing agreement to support the development of a GMP-compliant T-cell receptor (TCR) natural killer (NK) cell therapy targeting the tumor-associated neoantigen, PRAME.
-
Miltenyi Biotec acquires biosensor company lino Biotech
3/15/2023
lino Biotech announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023.
-
Miltenyi Biotec offers automated and closed adherent cell culture solutions on CliniMACS Prodigy®
7/14/2020
Miltenyi Biotec announced the immediate availability of its new CliniMACS Prodigy® Adherent Cell Culture System.
-
Miltenyi Biotec launches world’s first fully automated light sheet microscope
5/28/2020
Miltenyi Biotec today announces the UltraMicroscope Blaze.
-
Biotech Bay, the bustling biotech industry around San Francisco in California, is home to many biopharma companies developing diagnostics, therapies, and vaccines to fight against coronavirus disease 2019 (COVID-19) and the virus that causes it, called SARS-CoV-2.
-
Miltenyi Biotec launches new tool for coronavirus-specific T cell research
4/1/2020
Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19.
-
IsoPlexis Continues Progress on Precision CAR-T cell Characterization with Recent Data Sets & Miltenyi Biotec, Inc. Technology Note
9/26/2019
IsoPlexis illustrates progress in CAR-T development & bioprocessing with funding, recent data sets, and co-marketing technology note with Miltenyi Biotec, Inc.
-
Cellenion and Miltenyi Biotec Sign Co-Marketing Agreement to Provide a Time and Cost-Efficient Solution for the Development of Monoclonal Cell Lines
7/12/2018
SCIENION AG and Miltenyi Biotec GmbH today announced that Scienion’s affiliate Cellenion and Miltenyi Biotec have signed a co-marketing agreement.
-
Lentigen Technology, A Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma
7/20/2017
-
After Filling 70 U.S. Positions This Year, Miltenyi Biotec Plans to Add 30 More U.S. Jobs in 2017
12/2/2016
-
Miltenyi Biotec, Inc. Webinar Spotlights Advances In Translational And Basic T Cell Research
6/14/2016
-
Miltenyi Biotec, Inc. And Cesca Therapeutics' Subsidiary Totipotentrx Announce Multi-Year Commercial Agreement For Bone Marrow Transplantation
10/28/2015
-
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation
8/14/2014
-
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia
1/24/2014
-
Miltenyi Biotec, Inc. Acquires Owl biomedical, Inc.
4/23/2013
-
Miltenyi Biotec, Inc. Partners With Terso Solutions, Inc. for a Fully Automated, On-Site Inventory Management Program
4/3/2013
-
Automated Cell Biology Workflows with Tecan And Miltenyi Biotec, Inc.
8/17/2010
-
Miltenyi Biotec, Inc.: Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells
10/29/2009
-
Miltenyi Biotec, Inc.'s Advanced Bag Design for Cryopreservation: The New CryoMACS(R) Freezing Bag
7/14/2009
-
Miltenyi Biotec, Inc.'s Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings
5/20/2009